Clinical Trials Browser

Locally Advanced or Metastatic Urothelial Bladder Cancer × tislelizumab × Genitourinary × Clear all

NCT04004221 2024-10-26

Study of Tislelizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer

Phase 2 Completed

113 enrolled 15 charts

Locally Advanced or Metastatic Urothelial Bladder Cancer